Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interleukin-1 receptor antagonist (anakinra) and insulin sensitivity in type 1 diabetes
2010-023479-24Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of anakinra in diabetes mellitus type 1 (T1D), sponsored by Radboud University Medical Center. Primary endpoint: whole body insulin sensitivity. Started Nov 2010; status: completed.
02
Drugs
anakinra
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2010-023479-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023479-24.